#$%^&*AU2017232049A120180412.pdf#####1001931675 ABSTRACT OF THE DISCLOSURE Disclosed is a method for assisting diagnosis of risk of progression of diabetic nephropathy, comprising measuring urinary apolipoprotein E (ApoE) concentration of a patient with diabetic nephropathy showing a urinary albumin/Cr ratio of 30 mg/gCr or more, and determining that the patient has a high risk of progressing diabetic nephropathy when the value of urinary ApoE concentration is equal to or greater than a predetermined threshold value.4/6 FIG. 2 11 22 33c 3r 33a 33b FIG. 3 33a -- ------------------------------- ?-----S2---302 STORAGE UNIT 22 301 303 MEASUREMENT RECEIVING CALCULATION DEVICE UNIT UNIT 33c 305 304 DISPLAY UNIT OUTPUT UNIT DETERMI INPUT UNIT 33b
